| Name | (5S)-5-(morpholine-4-carbonyl)pyrrolidin-2-one |
|---|---|
| Synonyms |
(S)-5-[(Morpholin-4-yl)carbonyl]pyrrolidin-2-one
(S)-4-((5-Oxo-2-pyrrolidinyl)carbonyl)morpholine EINECS 286-118-5 (S)-5-(morpholine-4-carbonyl)pyrrolidin-2-one 2-Pyrrolidinone,5-(4-morpholinylcarbonyl)-,(5S) Morpholine,4-[(5-oxo-2-pyrrolidinyl)carbonyl]-,(S)-(9CI) |
| Molecular Formula | C9H14N2O3 |
|---|---|
| Molecular Weight | 198.21900 |
| Exact Mass | 198.10000 |
| PSA | 58.64000 |
| Index of Refraction | 1.524 |
|
~%
85187-29-7 |
| Literature: NOVARTIS AG Patent: WO2008/83967 A2, 2008 ; Location in patent: Page/Page column 89 ; |
|
~%
85187-29-7 |
| Literature: NOVARTIS AG Patent: WO2008/83967 A2, 2008 ; Location in patent: Page/Page column 91 ; |
|
~%
85187-29-7 |
| Literature: NOVARTIS AG Patent: WO2008/83967 A2, 2008 ; Location in patent: Page/Page column 89-90 ; |
|
~%
Detail
|
| Literature: NOVARTIS AG Patent: WO2008/83967 A2, 2008 ; Location in patent: Page/Page column 92 ; |